Literature DB >> 27719839

Neurologic diagnostic criteria for functional neurologic disorders.

C Gasca-Salas1, A E Lang2.   

Abstract

The diagnosis of functional neurologic disorders can be challenging. In this chapter we review the diagnostic criteria and rating scales reported for functional/psychogenic sensorimotor disturbances, psychogenic nonepileptic seizures (PNES) and functional movement disorders (FMD). A recently published scale for sensorimotor signs has some limitations, but may help in the diagnosis, and four motor and two sensory signs have been reported as highly reliable. There is good evidence using eight specific signs for the differentiation of PNES from seizures. Recently, diagnostic criteria were developed for PNES; their sensitivity and specificity need to be evaluated. The definitive diagnosis of PNES can be made by recording typical positive features during the spells, and in a low proportion of cases, where the distinction with an organic etiology cannot easily be done, a normal electroencephalogram suggests the diagnosis. FMD diagnosis relies on diagnostic criteria, which have been refined over time and may be supplemented by laboratory tests in some phenotypes. Rating scales for PNES and FMD could be useful for severity measures, but several limitations remain to be addressed.
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  certainty; diagnostic criteria; functional; movement disorders; neurologic disorders; nonepileptic seizures; psychogenic; rating scales; reliability; sensorimotor disturbances

Mesh:

Year:  2016        PMID: 27719839     DOI: 10.1016/B978-0-12-801772-2.00017-5

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  7 in total

1.  Evaluation of Individualized Multi-Disciplinary Inpatient Treatment for Functional Movement Disorders.

Authors:  Tamara Schmidt; Georg Ebersbach; Henriette Oelsner; Anette Sprock; Inke R König; Tobias Bäumer; Alexander Münchau; Anne Weissbach
Journal:  Mov Disord Clin Pract       Date:  2021-06-24

2.  Inactivated COVID-19 vaccine induced acute stroke-like focal neurologic symptoms: a case series.

Authors:  Duangnapa Roongpiboonsopit; Chichaya Nithisathienchai; Wasan Akarathanawat; Krittanon Lertutsahakul; Jarturon Tantivattana; Anand Viswanathan; Nijasri Charnnarong Suwanwela
Journal:  BMC Neurol       Date:  2022-06-07       Impact factor: 2.903

3.  Functional Neurological Symptom Disorder in Children and Adolescents within Medical Settings.

Authors:  Karen E Weiss; Kyle J Steinman; Ian Kodish; Leslie Sim; Sharon Yurs; Celeste Steggall; Aaron D Fobian
Journal:  J Clin Psychol Med Settings       Date:  2021-03

Review 4.  Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System.

Authors:  Kazuya Yoshida
Journal:  Toxins (Basel)       Date:  2022-04-14       Impact factor: 5.075

Review 5.  Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders.

Authors:  Alberto J Espay; Selma Aybek; Alan Carson; Mark J Edwards; Laura H Goldstein; Mark Hallett; Kathrin LaFaver; W Curt LaFrance; Anthony E Lang; Tim Nicholson; Glenn Nielsen; Markus Reuber; Valerie Voon; Jon Stone; Francesca Morgante
Journal:  JAMA Neurol       Date:  2018-09-01       Impact factor: 18.302

6.  Functional dystonia: A case-control study and risk prediction algorithm.

Authors:  Christopher D Stephen; David L Perez; Lori B Chibnik; Nutan Sharma
Journal:  Ann Clin Transl Neurol       Date:  2021-03-16       Impact factor: 4.511

Review 7.  Neuroimaging in Functional Neurological Disorder: State of the Field and Research Agenda.

Authors:  David L Perez; Timothy R Nicholson; Ali A Asadi-Pooya; Indrit Bègue; Matthew Butler; Alan J Carson; Anthony S David; Quinton Deeley; Ibai Diez; Mark J Edwards; Alberto J Espay; Jeannette M Gelauff; Mark Hallett; Silvina G Horovitz; Johannes Jungilligens; Richard A A Kanaan; Marina A J Tijssen; Kasia Kozlowska; Kathrin LaFaver; W Curt LaFrance; Sarah C Lidstone; Ramesh S Marapin; Carine W Maurer; Mandana Modirrousta; Antje A T S Reinders; Petr Sojka; Jeffrey P Staab; Jon Stone; Jerzy P Szaflarski; Selma Aybek
Journal:  Neuroimage Clin       Date:  2021-03-11       Impact factor: 4.881

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.